These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33096056)

  • 21. Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.
    Ramos GS; Vallejos VMR; Ladeira MS; Reis PG; Souza DM; Machado YA; Ladeira LO; Pinheiro MBV; Melo MN; Fujiwara RT; Frézard F
    Biomed Pharmacother; 2021 Feb; 134():111120. PubMed ID: 33341671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa.
    Costa Lima S; Rodrigues V; Garrido J; Borges F; Kong Thoo Lin P; Cordeiro da Silva A
    Int J Antimicrob Agents; 2012 May; 39(5):424-30. PubMed ID: 22398197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
    Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
    Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis.
    Tempone AG; Mortara RA; de Andrade HF; Reimão JQ
    Int J Antimicrob Agents; 2010 Aug; 36(2):159-63. PubMed ID: 20554161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity and Cell-Death Pathway in
    Scariot DB; Volpato H; Fernandes NS; Soares EFP; Ueda-Nakamura T; Dias-Filho BP; Din ZU; Rodrigues-Filho E; Rubira AF; Borges O; Sousa MDC; Nakamura CV
    Front Cell Infect Microbiol; 2019; 9():208. PubMed ID: 31259161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.
    Reis LES; Fortes de Brito RC; Cardoso JMO; Mathias FAS; Aguiar Soares RDO; Carneiro CM; de Abreu Vieira PM; Ramos GS; Frézard FJG; Roatt BM; Reis AB
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis.
    Zorgi NE; Arruda LV; Paladine I; Roque GAS; Araújo TF; Brocchi M; Barral M; Sanchiz Á; Requena JM; Abánades DR; Giorgio S
    Mol Immunol; 2020 Nov; 127():95-106. PubMed ID: 32949849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the Anti-Leishmania (Leishmania) infantum Activity of Some Natural Sesquiterpene Lactones.
    Wulsten IF; Costa-Silva TA; Mesquita JT; Lima ML; Galuppo MK; Taniwaki NN; Borborema SET; Da Costa FB; Schmidt TJ; Tempone AG
    Molecules; 2017 Apr; 22(5):. PubMed ID: 28441357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR.
    Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
    Exp Parasitol; 2011 Jun; 128(2):111-5. PubMed ID: 21354141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of new terpenoid derivatives against Leishmania infantum and Leishmania braziliensis.
    Ramírez-Macías I; Marín C; Chahboun R; Olmo F; Messouri I; Huertas O; Rosales MJ; Gutierrez-Sánchez R; Alvarez-Manzaneda E; Sánchez-Moreno M
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):370-6. PubMed ID: 22510833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.
    Bilbao-Ramos P; Serrano DR; Ruiz Saldaña HK; Torrado JJ; Bolás-Fernández F; Dea-Ayuela MA
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32204358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control.
    Antinarelli LMR; Midlej V; da Silva EDS; Coelho EAF; da Silva AD; Coimbra ES
    Chem Biol Interact; 2023 Feb; 371():110333. PubMed ID: 36592711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.
    Gontijo VS; Colombo FA; Ferreira Espuri P; Freitas PG; Nunes JB; Alves LB; Veloso MP; Alves RB; Freitas RP; Marques MJ
    Exp Parasitol; 2021; 226-227():108123. PubMed ID: 34144040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.